About Joseph Connor
Form D filings for MBF Therapeutics in 2024 list Joseph Connor as director.
Joseph Connor first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Joseph Connor in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joseph Connor works with at each company, as listed on that company's latest Form D.
MBF Therapeutics, Inc. · Form D, Jan 8, 2024
DT
Dhiren Thakker
Director
AP
Aris Persidis
Director
LK
Lorraine Keller
Executive officer
TT
Thomas Tillett
President and director
CC
Christopher Cashman
Director